H1 Stock
H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems.
Sign up today and learn more about H1 Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About H1 Stock
H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organization. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. It was founded in 2017 and is based in New York, New York.
Funding History
| March 2020 | $12.9M |
|---|---|
| December 2020 | $58.0M |
Management
CEO and Co-Founder
Ariel Katz
Co-Founder
Ian Sax
VP of Commercial Strategy and Operations
Zachary Feuerstein
Director Of Innovation
Callum Booker
Chief Of Staff
Andrew Stickney
VP Innovation
Devin Basinger
Senior Director
Raymond Jacobs
CCO
Marc Eigner
Board Member
Greg Yap
Board Observer
Jean-Paul Sanday
Director, Customer Support
Jason Viglione
Board Observer
Michael Miao
Board Observer
Deena Shakir
Press
globenewswire - Apr, 5 2024
H1 Honored With Spot On the New York Digital Health 100 For Third Straight Yearglobenewswire - Apr, 5 2024
H1 Recognized as One of Forbes' Best Startup Employers invator - Jun, 10 2022
H1 raises $23M Series C extension to deploy healthcare provider datafiercehealthcare - Feb, 17 2022
H1 picks up Faculty Opinions to add top scientific researchers to growing healthcare networkbizjournals - Feb, 17 2022
Health care data company H1 buys U.K.-based scientific research siteEquityZen Recognized As:
